The United States is unique among economically advanced nations in its reliance on employers to provide health benefits voluntarily for workers and their families. Although it is well known that this system fails to reach millions of these individuals as well as others who have no connection to the work place, the system has other weaknesses. It also has many advantages. Because most proposals for health care reform assume some continued role for employers, this book makes an important contribution by describing the strength and limitations of the current system of employment-based health benefits. It provides the data and analysis needed to understand the historical, social, and economic dynamics that have shaped present-day arrangements and outlines what might be done to overcome some of the access, value, and equity problems associated with current employer, insurer, and government policies and practices. Health insurance terminology is often perplexing, and this volume defines essential concepts clearly and carefully.Using an array of primary sources, it provides a store of information on who is covered for what services at what costs, on how programs vary by employer size and industry, and on what governments do--and do not do--to oversee employment-based health programs. A case study adapted from real organizations' experiences illustrates some of the practical challenges in designing, managing, and revising benefit programs. The sometimes unintended and unwanted consequences of employer practices for workers and health care providers are explored. Understanding the concepts of risk, biased risk selection, and risk segmentation is fundamental to sound health care reform. This volume thoroughly examines these key concepts and how they complicate efforts to achieve efficiency and equity in health coverage and health care. With health care reform at the forefront of public attention, this volume will be important to policymakers and regulators, employee benefit managers and other executives, trade associations, and decisionmakers in the health insurance industry, as well as analysts, researchers, and students of health policy.
Marilyn J. Field and Harold T. Shapiro, Editors; Committee on Employment-Based Health Benefits, Institute of Medicine
1 FRONT MATTER; 2 SUMMARY; 3 1 BACKGROUND AND INTRODUCTION; 4 2 ORIGINS AND EVOLUTION OF EMPLOYMENT-BASED HEALTH BENEFITS; 5 3 EMPLOYMENT-BASED HEALTH BENEFITS TODAY; 6 4 WHATD DOES EMPLOYER MANAGEMENT OF HEALTH BENEFITS INVOLVE? OVERVIEW AND CASE STUDY; 7 5 RISK SELECTION, RISK SHARING, AND POLICY; 8 6 HEALTH CARE COSTS: MORE QUESTIONS THAN ANSWERS; 9 7 FINDINGS AND RECOMMENDATIONS; 10 REFERENCES; 11 APPENDIXES; 12 A OPINION SURVEYS ON EMPLOYMENT-BASED HEALTH BENEFITS AND RELATED ISSUES; 13 B REGULATION OF EMPLOYMENT-BASED HEALTH BENEFITS: THE INTERSECTION OF STATE AND FEDERAL LAW; 14 C PARTICIPANTS IN MEETINGS HELD IN CONJUNCTION WITH PROJECT; 15 D BIOGRAPHIES OF COMMITTEE MEMBERS; 16 GLOSSARY AND ACRONYMS; 17 INDEX
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Division of Health Care Services, Committee on Medicare Coverage Extensions, Lee Zwanziger, Robert L. Lawrence, Marilyn J. Field
Institute of Medicine, Board on Health Sciences Policy, Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), Thomas F. Boat, Marilyn J. Field
Institute of Medicine, Board on Health Sciences Policy, Committee on Accelerating Rare Diseases Research and Orphan Product Development, Thomas F. Boat, Marilyn J. Field